Biomimetic Theranostic Agents with Superior NIR-II Photoacoustic and Magnetic Resonance Imaging Performance for Targeted Photothermal Therapy of Prostate Cancer

The accurate diagnosis and treatment of prostate cancer at an early stage is crucial to reduce mortality rates. However, the limited availability of theranostic agents with active tumor-targeting abilities hinders imaging sensitivity and therapeutic efficiency. To address this challenge, we have dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ling, Yang, Shangpo, Zheng, Ziliang, Li, Qingshuang, Liu, Chenchen, Hu, Dehong, Liu, Zhou, Zhang, Xiaoping, Zhang, Ruiping, Gao, Duyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305050/
https://www.ncbi.nlm.nih.gov/pubmed/37376066
http://dx.doi.org/10.3390/pharmaceutics15061617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305050/
https://www.ncbi.nlm.nih.gov/pubmed/37376066
http://dx.doi.org/10.3390/pharmaceutics15061617

Ejemplares similares